Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting
Clinical trial NCT03743766 · COMPLETED
Trial details
- NCT number
- NCT03743766
- Sponsor
- John Kirkwood
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2024-07-03
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.